Phio Pharmaceuticals Corp. Stock price
Is Phio Pharmaceuticals Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Phio Pharmaceuticals Corp. Stock Analysis
Analyst Opinions
7 Analysts have issued a Phio Pharmaceuticals Corp. forecast:
Analyst Opinions
7 Analysts have issued a Phio Pharmaceuticals Corp. forecast:
Don't miss a Thing! We will send you all news about Phio Pharmaceuticals Corp. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
| Head office | United States |
| CEO | Mr. Bitterman |
| Employees | 6 |
| Founded | 2011 |
| Website | phiopharma.com |


